Related Experiment Videos
Juvenile-onset obesity and deficits in caloric regulation in MSG-treated rats
Insights
Monosodium glutamate (MSG) injections in newborn rats led to obesity but paradoxically reduced body weight and food intake. These MSG-treated rats showed impaired caloric intake regulation in adulthood.
Area of Science:
- Neuroscience
- Endocrinology
- Obesity Research
Background:
- Monosodium glutamate (MSG) is a common food additive.
- Neonatal exposure to MSG has been linked to potential adverse effects in animal models.
- Understanding the long-term impact of early-life MSG exposure on metabolic regulation is crucial.
Purpose of the Study:
- To investigate the effects of neonatal monosodium glutamate (MSG) administration on caloric regulation and the development of obesity in rats.
- To assess the long-term consequences of MSG exposure on body weight, food intake, and appetite control.
Main Methods:
- Parenteral injections of MSG (2 mg/g or 4 mg/g) were administered to neonatal rats for the first 20 days of life.
- Obesity was assessed using Lee Indices at various ages (22, 70, and 130 days).
- Caloric intake regulation was tested in adulthood using diets of varying caloric densities.
Main Results:
- Rats receiving 4 mg/g MSG exhibited significantly higher obesity indices compared to controls at all measured ages.
- Despite increased obesity, MSG-treated rats showed significantly lower body weight and food intake than controls.
- MSG-treated rats demonstrated an impaired ability to regulate caloric intake, failing to adjust consumption appropriately across different diet densities.
Conclusions:
- Neonatal MSG exposure can induce obesity in rats while simultaneously impairing caloric intake regulation in adulthood.
- The observed regulatory deficits in MSG-treated rats resemble those seen in animals with ventromedial hypothalamus lesions.
- This animal model provides valuable insights into juvenile-onset obesity and the neurobiological mechanisms of appetite control.
Abstract:
Caloric regulation and the development of obesity were examined in rats which had received parenteral injections of monosodium glutamate (MSG) as neonates. Rats were injected with either 2 mg/g or 4 mg/g MSG on alternate days for the first 20 days of life. Lee Indices of obesity were calculated at 22, 70, and 130 days of age. Animals in the 4 mg/g group were significantly more obese than controls at all three ages. However, both food intake and body weight of this group were significantly lower than those of controls. In adulthood, the ability to regulate caloric intake was tested by allowing animals access to diets of varying caloric densities. While control animals maintained relatively constant caloric intakes across dietary conditions, MSG-treated animals demonstrated an inability to respond to caloric challenges. Treated animals decreased caloric intake on a diluted diet and consumed more calories than controls when presented with a calorically dense diet. This inability to regulate caloric intake is compared with regulatory deficits observed in animals sustaining lesions of the ventromedial hypothalamus. The value of an animal model of juvenile-onset obesity is also discussed.